Filing Flows › Cryo Cell International (CCEL) › Q2 FY26 › vs Q2 FY25
Cryo Cell International (CCEL) Q2 FY26 vs Q2 FY25 (year over year)
Cryo Cell International's revenue fell $153K (-2%) from $7.9M in Q2 FY25 to $7.8M in Q2 FY26. The biggest changes: Processing and Storage Fees −$156K (-2%); Public Banking +$4K (+9%); Product −$254 (-2%). Operating margin 15.4% against 18.8% (-3.4 pts).
Cryo Cell International, Q2 FY26: revenue $7.8M (-2% year over year), operating margin 15.4%, net earnings $555K, operating cash flow $1.8M. The chart draws each line against Q2 FY25, the increases inside each band.
Margins
| Q2 FY26 | Q2 FY25 | Change | |
|---|---|---|---|
| Operating margin | 15.4% | 18.8% | -3.4 pts |
| Net margin | 7.1% | 4.5% | +2.6 pts |
| Free cash flow margin | 23.3% | 8.1% | +15.2 pts |
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Processing and Storage Fees | $7.7M | $7.9M | −$156K | -2% |
| Public Banking | $46K | $43K | $4K | +9% |
| Product | $14K | $14K | −$254 | -2% |
| Revenue | $7.8M | $7.9M | −$153K | -2% |
| Operating profit | $1.2M | $1.5M | −$295K | -20% |
| Costs & expenses | $6.6M | $6.4M | $143K | +2% |
| Pre-tax earnings | $828K | $575K | $253K | +44% |
| Other expense, net | $370K | $918K | −$548K | -60% |
| Cost of revenue | $1.7M | $1.9M | −$180K | -10% |
| Research & development | $100K | $132K | −$32K | -24% |
| SG&A | $4.6M | $4.3M | $360K | +8% |
| Other operating costs | $184K | $190K | −$6K | -3% |
| Net earnings | $555K | $356K | $199K | +56% |
| Income tax | $273K | $219K | $54K | +25% |
| Depreciation & amortization | $244K | $250K | −$6K | -3% |
| Share-based compensation | $65K | $40K | $25K | +62% |
| Working capital & other | $983K | $61K | $922K | 16× |
| Operating cash flow | $1.8M | $707K | $1.1M | +161% |
| Free cash flow (OCF − capex) | $1.8M | $645K | $1.2M | +181% |
| Capital expenditures | $33K | $62K | −$30K | -48% |
Questions
How much did Cryo Cell International's revenue grow year over year in Q2 FY26?
Cryo Cell International's revenue fell $153K (-2%) from $7.9M in Q2 FY25 to $7.8M in Q2 FY26.
What drove Cryo Cell International's revenue change in Q2 FY26?
Processing and Storage Fees −$156K (-2%); Public Banking +$4K (+9%); Product −$254 (-2%).